Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
As of: Nov 16, 2026 · 3:54 PM EST

Elite Pharmaceuticals (ELTP) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Elite Pharmaceuticals (ELTP) posted Liabilities and Shareholders Equity of $144.29 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 23.1% from $117.25 million a year earlier and up 3.3% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Liabilities and Shareholders Equity came in at $138.29 million, up 43.5% from FY2025.

  • Annual Liabilities and Shareholders Equity has increased for seven consecutive fiscal years, with a five-year compound annual growth rate of 39.5% (FY2021 to FY2026).
  • In prior fiscal years, Elite Pharmaceuticals' Liabilities and Shareholders Equity was $96.39 million in FY2025 (+15.2%), $83.65 million in FY2024 (+104.6%), $40.9 million in FY2023 (+16.4%) and $35.15 million in FY2022 (+34.2%).
  • The fiscal Q2 2027 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to fiscal Q4 2009.
  • On a year-over-year basis, Liabilities and Shareholders Equity has increased in each of the last 13 quarters, with growth averaging 28.5% over the last eight quarters.
  • The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q4 2024, with growth of 104.6%; the weakest was fiscal Q1 2024, with a decline of 3.3%.
  • According to Business Quant data, Liabilities and Shareholders Equity for the three prior fiscal quarters was $139.67 million (Q1 2027), $138.29 million (Q4 2026) and $126.41 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 197.43 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 147.68 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 119.92 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 51.41 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 205.00 Bn
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 144.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 144.29 Mn
Jun 30, 2026 139.67 Mn
Mar 31, 2026 138.29 Mn
Dec 31, 2025 126.41 Mn
Sep 30, 2025 117.25 Mn
Jun 30, 2025 111.34 Mn
Mar 31, 2025 96.39 Mn
Dec 31, 2024 90.76 Mn
Sep 30, 2024 88.20 Mn
Jun 30, 2024 87.85 Mn
Mar 31, 2024 83.65 Mn
Dec 31, 2023 74.70 Mn
Sep 30, 2023 70.72 Mn
Jun 30, 2023 46.50 Mn
Mar 31, 2023 40.90 Mn
Dec 31, 2022 52.72 Mn
Sep 30, 2022 50.34 Mn
Jun 30, 2022 48.11 Mn
Mar 31, 2022 35.15 Mn
Dec 31, 2021 31.95 Mn
API Access

Elite Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ELTP&period=max&api_key=YOUR_API_KEY